Clint Mitchell

Radiation Oncology Associates — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

31h-index3.0kcitations81works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sphingolipid Metabolism and Signaling(24), Cell death mechanisms and regulation(15), Cancer-related Molecular Pathways(13), Endoplasmic Reticulum Stress and Disease(11), Enzyme function and inhibition(11)

Publications81 total

Data from Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells <i>in vitro</i> via suppression of c-FLIP-s levels and activation of CD95
2023Open Access
Supplementary Data from 17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca<sup>2+</sup>-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species
2023Open Access
Data from Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
2023Open Access
Data from Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells <i>in vitro</i> via suppression of c-FLIP-s levels and activation of CD95
2023Open Access
Data from 17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca<sup>2+</sup>-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species
2023Open Access
Supplementary Material from Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells <i>in vitro</i> via suppression of c-FLIP-s levels and activation of CD95
2023Open Access
Supplementary Figures S1-S18 from Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
2023Open Access
Data from Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
2023Open Access
Data from 17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca<sup>2+</sup>-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species
2023Open Access
Supplementary Figures S1-S18 from Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
2023Open Access
Supplementary Data from 17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca<sup>2+</sup>-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species
2023Open Access
Supplementary Material from Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells <i>in vitro</i> via suppression of c-FLIP-s levels and activation of CD95
2023Open Access
Supplementary Figure 2 from Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
2023Open Access
Supplementary Figures 1-11 from PERK–Dependent Regulation of Ceramide Synthase 6 and Thioredoxin Play a Key Role in <i>mda</i>-7/IL-24–Induced Killing of Primary Human Glioblastoma Multiforme Cells
2023Open Access
Supplementary Materials, Figure Legends 1-3 from Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
2023Open Access
Supplementary Materials, Figure Legends 1-3 from Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
2023Open Access
Supplementary Figure 3 from Targeting Sphingosine Kinase 1 Inhibits Akt Signaling, Induces Apoptosis, and Suppresses Growth of Human Glioblastoma Cells and Xenografts
2023Open Access
Data from PERK–Dependent Regulation of Ceramide Synthase 6 and Thioredoxin Play a Key Role in <i>mda</i>-7/IL-24–Induced Killing of Primary Human Glioblastoma Multiforme Cells
2023Open Access
Supplementary Figures 1-8 from Vorinostat and Sorafenib Increase CD95 Activation in Gastrointestinal Tumor Cells through a Ca<sup>2+</sup>-<i>De novo</i> Ceramide-PP2A-Reactive Oxygen Species–Dependent Signaling Pathway
2023Open Access
Data from PERK–Dependent Regulation of Ceramide Synthase 6 and Thioredoxin Play a Key Role in <i>mda</i>-7/IL-24–Induced Killing of Primary Human Glioblastoma Multiforme Cells
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Paul Dent(44), Adly Yacoub(32), Steven Grant(30), Paul B. Fisher(22), Margaret A. Park(19), Mohamed Rahmani(15), Hossein A. Hamed(13), David T. Curiel(10), Michael P. Hagan(10), Guo Zhang(9), Aditi Pandya Martin(9), Sarah Spiegel(8), Steven Grant(8), Teneille Walker(8), Philip B. Hylemon(7), Elaine Studer(7), Jeremy C. Allegood(6), Song Iy Han(6), John D. Roberts(5), Devanand Sarkar(5)